The poultry mycotoxin inhibition market was valued at USD 641.9 million in 2025 and is forecast to register a 7.5% CAGR between 2026 and 2036. In 2026, direct sales hold 41.0% within the sales channel segment, poultry represents 39.0% of the livestock category and dry accounts for 38.5% of form demand.